Legend Biotech Corp is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LEGN is expected to report earnings to fall 242.00% to -4 cents per share on November 24
Q3'25
Est.
$-0.04
Q2'25
Beat
by $0.15
Q1'25
Missed
by $0.06
Q4'24
Beat
by $0.09
Q3'24
Missed
by $0.01
The last earnings report on August 11 showed earnings per share of 2 cents, beating the estimate of -11 cents. With 869.11K shares outstanding, the current market capitalization sits at 6.92B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LEGN showed earnings on August 11, 2025. You can read more about the earnings report here.